uly 06, 2020, 11:21 PM Sanofi-Aventis has urged the U.S. Supreme Court to weigh in on its patent row with Mylan, arguing in a recent petition that the Federal Circuit's decision that the structure of the Patent Trial and Appeal Board is unconstitutional should now apply to all companies, even those that didn't raise